This updated research paper from the Treatment Action Campaign seeks to respond with reasoned analysis to a number of inaccurate claims that have been made by the pharmaceutical industry particularly in light of the PharmaGate scandal. The evidence highlights how South Africa’s current intellectual property system allows exploitation by foreign companies whilst impeding access to medicines and the growth of our local industry. Additionally, the paper demonstrates that there is little evidence to back up industry claims that the adoption of public health safeguards in South Africa will...Read more
Intimidation and death threats of activists must end now!
The Treatment Action Campaign (TAC) is deeply concerned with the quality of healthcare services and leadership in the Free State.
In 2013 we received frequent reports of medicine stockouts and poor conditions at clinics and hospitals in the Free State. In order to get a clearer picture of medicines stockouts across the province and country TAC was one of the partners that established the Stop Stockouts Project (SSP) in 2013.
A carefully researched report released by the SSP...
500 activists from the Treatment Action Campaign (TAC) picketed yesterday at the offices of the pharmaceutical company Merck, Sharp and Dohme (MSD) over their involvement in the controversial PharmaGate plot. The plot aimed to undermine and substantially delay South Africa’s long awaited IP policy – a policy that outlines several critical reforms to South Africa’s existing patent legislation. These reforms are essential to ensuring continued and improved access to essential medicines for all who live in South Africa.
Why is the PharmaGate plot unacceptable?
Today the Treatment Action Campaign (TAC), SECTION27 and Doctors without Borders (MSF) held a public action outside an Executive Board meeting of the Innovative Pharmaceutical Association South Africa (IPASA).
There has been significant public outrage about a proposal exposed by the Mail & Guardian on 16 January 2014, outlining a R6million deceptive plot to undermine and delay South Africa’s IP Policy reform process. Through incorporating legal safeguards into the existing patent system, these moderate reforms will increase access to affordable life-saving medicines in...
CAPE TOWN, 21st January: A leaked industry email published by Knowledge Ecology International (KEI) yesterday proves the direct involvement of multinational pharmaceutical companies and the Innovative Pharmaceuticals Association of South Africa (IPASA) in the PharmaGate scandal. Despite attempting to distance themselves from the plot in public statements since the Mail & Guardian broke the story on Friday 17 January 2014, the leaked email illustrates that both IPASA and US-based industry body PhRMA (the Pharmaceutical Researchers and Manufacturers of America) actively selected the “...Read more